Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.

Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, Jiang Y, Cheng X, Zhu C, Xia Y. · 2020

Read Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. by Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, Jiang Y, Cheng X, Zhu C, Xia Y. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7473317.txt.

Introduction

Han and co-authors profile blood cytokines in COVID-19 patients from Wuhan, China. Most patients stayed mild, but some fell into respiratory failure and organ damage. The team tested if a cytokine storm marks the severe path.

They enrolled 102 patients and 45 healthy volunteers for the study at Renmin Hospital in the city of Wuhan. Patients split into moderate, severe, and critical groups. Cytokine and CRP levels ran higher in patients than in healthy controls. IL-6 and IL-10 stood out: both ran far higher in the critical group. Each could predict disease severity in their tests. IL-10 levels also tracked with CRP amounts. The authors back IL-6 and IL-10 as warning markers. Cutting inflammation may guard lungs in severe cases.

Catalog record

CREATORHan H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, Jiang Y, Cheng X, Zhu C, Xia Y.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7473317

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors By Huan Han, Qingfeng Ma, Cong Li, Rui Liu, Li Zhao, Wei Wang, Pingan Zhang, Xinghui Liu, Guosheng Gao, Fang Liu, Yingan Jiang, Xiaoming Cheng Published in: Emerging Microbes & Infections DOI: 10.1080/22221751.2020.1770129 ABSTRACT ABSTRACT Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, it has rapidly spread across many other countries. While the majority of patients were considered mild, critically ill patients involving respiratory failure and multiple organ dysfunction syndrome are not uncommon, which could result death. We hypothesized that cytokine storm is associated with severe outcome. We enrolled 102 COVID-19 patients who were admitted to Renmin Hospital (Wuhan, China). All patients were classified into moderate, severe and critical groups according to their symptoms. 45 control samples of healthy volunteers were also included. Inflammatory cytokines and C-Reactive Protein (CRP) profiles of serum samples were analyzed by specific immunoassays. Results showed that COVID-19 patients have higher serum level of cytokines (TNF-α, IFN-γ, IL-2, IL-4, IL-6 and IL-10) and CRP than control individuals. Within COVID-19 patients, serum IL-6 and IL-10 levels are significantly higher in critical group (n = 17) than in moderate (n = 42) and severe (n = 43) group. The levels of IL-10 is positively correlated with CRP amount (r = 0.41, P < 0.01). Using univariate logistic regression analysis, IL-6 and IL-10 are found to be predictive of disease severity and receiver operating curve analysis could further confirm this result (AUC = 0.841, 0.822 respectively). Our result indicated higher levels of cytokine storm is associated with more severe disease development. Among them, IL-6 and IL-10 can be used as predictors for fast diagnosis of patients with higher risk of disease deterioration. Given the high levels of cytokines induced by SARS-CoV-2, treatment to reduce inflammation-related lung damage is critical. KEYWORDS: SARS-CoV-2, COVID-19, cytokine storm, inflammatory cytokines, Interleukin 6, Interleukin 10 INTRODUCTION Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported in December, 2019, and the affected countries has grown rapidly and recently WHO has been declared it as a pandemic. Majority of patients with COVID-19 are asymptomatic or experienced mild to severe respiratory illness. However, fatal cases with multi-organ and systemic manifestations like sepsis, septic shock, and multiple organ dysfunction syndromes (MODS) have also been observed [1]. The laboratory study has shown SARS-CoV-2 is cytopathic and this could have caused the first damage to the lung as shown by pathological examination [2]. Accompanied by viral amplification, host immune responses become activated, which is supposed to clear the virus and cure the patients. But why a portion of patients had more severe disease development like MODS is still unknown. We hypothesized cytokine storm plays important role in the pathogenesis of severe cases of COVID-19 [1,3]. Cytokine storms can be triggered by various infectious or non-infectious diseases [4], and cause severe damages to multiple organs. Pathogen infections are recognized by the immune system, which consists of two types of responses: an innate immune response that recognizes pathogen-associated molecular patterns (PAMPs) and an antigen-specific adaptive immune response. In both responses, there are several activated cells of the immune system, which play a key role in establishing the environment of cytokines [5,6]. However, exaggerated, excessive synthesized cytokines lead to an acute, severe systemic inflammatory response known as “cytokine storm”. Several experimental studies and clinical trials suggested that cytokine storm correlated directly with tissue injury and an unfavourable prognosis of severe lung diseases. Until now, the cytokine profile of COVID-19 patient with different disease severity is not clear. The aim of this study is to investigate which cytokines were involved in cytokine storm of COVID-19 and the value of cytokines in diagnosis and treatment of the COVID-19. MATERIALS AND METHODS Study design This study was approved by the institutional ethics board of Renmin Hospital of Wuhan University (No.WDRY2020-K066). All patients (n = 102) with COVID-19 enrolled in this study were diagnosed with SARS-CoV-2 infection and admitted to Renmin Hospital of Wuhan University (Wuhan, China) between Jan 2020 and Feb 2020. All baseline serum samples were collected immediately after hospital admission and were further divided into moderate (n = 42), severe (n = 43) and critical (n = 17) according to China's novel coronavirus pneumonia diagnosis and treatment guideline (5th edition) [7–10]. Some of them (29 moderate, 23 severe and 14 critical) were enrolled into the longitudinal study, and the serum samples were collected multiple times during hospitalization. The detailed criteria are listed as following: Moderate group: Fever; respiratory symptoms; imaging finding of pneumonia. Severe group: patients have any of the following conditions: Respiratory distress, RR ≥30 times / minute; The oxygen saturation (SpO2) ≤93% at rest; Oxygen partial pressure (PaO2)/oxygen concentration (FiO2) in arterial blood ≤300 mmHg; >50% lung imaging progress in the short term within 24–48 h. Critical group: patients have any of the following conditions: Respiratory failure and mechanical ventilation required; Shock; Combining other organ failure, intensive care unit is needed. Serum samples collected from 45 healthy volunteers were served as controls. All individuals included the current study have been confirmed with no infection of other pathogenic microorganisms like, respiratory virus other than SARS-CoV-2, HBV, HCV and HIV. LABORATORY EXAMINATION OF BLOOD SAMPLES Approximately 3∼5 ml of peripheral blood was obtained with collection tube from the subjects in each group, serum samples were separated by 2000 rpm /20 min centrifugation. Serum cytokines were tested using BD FACSCalibur flow cytometer (BD FACSCalibur, BD Bioscience, CA) and human Th1/Th2 cytokines kit (Ceger, Hangzhou, China) following manufactures’ instructions. Briefly, 25ul of serum sample was mixed with capture antibody coupled beads, and then 25ul fluorescent labelled detection antibodies. The samples were mixed and incubated at room temperature in the dark. After 2.5 h incubation, the beads was washed and resuspended with PBS. A recombinant protein standard for each cytokine that provides an internal control was included. The detection was performed by BD FACSCalibur flow cytometer. The detection range of each cytokine is 2.5 pg/ml to 5000 pg/ml. C-reactive protein (CRP) was tested using i-CHROMA immunofluorescence analyzer and supporting kits (i-CHROMA Reader, Boditech Med Inc, Korean). STATISTICAL ANALYSIS SPSS 22.0 statistical software was used for statistical analysis. Count data were analyzed by the χ2 test, non-normal distribution measurement data were expressed as median (p25, p75) and were analyzed by nonparametric Mann–Whitney U-test or Wilcoxon signed-rank test. Normally distributed measurement data were expressed as the mean ± SD and were analyzed by variance analysis. Correlations between paired data were analyzed using the Spearman rank correlation coefficient. A P value < 0.05 indicates statistical significance. RESULTS Inflammatory makers in COVID-19 patients and controls The basic information of enrolled individuals was listed in Supplementary Table S1, no significant difference of sex and age were found among the 4 groups (P > 0.05). The time of sampling, which indicated as days after patient developed fever, also showed no significant difference among three COVID-19 groups (see Supplementary Table 1). We first compared the levels of IFN-γ, TNF-α, IL-2, IL-4, IL-6 and IL-10 in serum samples from control group and COVID-19 patients. As shown in Figure 1, the values of cytokines and CRP were significantly higher in

Read the complete text